Co-Authors
This is a "connection" page, showing publications co-authored by Franco Rongioletti and Cristina Mugheddu.
Connection Strength
3.130
-
Safety of secukinumab treatment in COVID-19 affected psoriatic patients. Dermatol Ther. 2021 Jan; 34(1):e14710.
Score: 0.922
-
COVID-19 pulmonary infection in erythrodermic psoriatic patient with oligodendroglioma: safety and compatibility of apremilast with critical intensive care management. J Eur Acad Dermatol Venereol. 2020 Aug; 34(8):e376-e378.
Score: 0.885
-
Successful guselkumab treatment in a psoriatic patient affected with Cornelia de Lange syndrome, and prosecution during the COVID-19 pandemic. Dermatol Ther. 2020 Jul; 33(4):e13433.
Score: 0.879
-
Clinical efficacy, speed of improvement and safety of apremilast for the treatment of adult Psoriasis during COVID-19 pandemic. Dermatol Ther. 2020 Jul; 33(4):e13722.
Score: 0.222
-
Psoriasis health care in the time of the coronavirus pandemic: insights from dedicated centers in Sardinia (Italy). J Eur Acad Dermatol Venereol. 2020 Jun; 34(6):e247-e248.
Score: 0.221